You are here

Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Spain Rehabilitation Center
Birmingham, Alabama, 35233 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Ischemic Stroke
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-85 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Diagnosis of ischemic stroke with an onset within 72 hours prior to start of study
agent administration, male or female.

- Supratentorial ischemic stroke involving the cortex documented by neurological exam
and confirmed by MRI.

- Stroke involving upper extremity.

- Subjects who received thrombolytic therapy may be enrolled and the use of antiplatelet
is acceptable.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Any other severe acute or chronic medical or psychiatric condition besides the stroke.

- Women of child bearing potential.

- Uncontrolled hypertension.

NCT01208233
Pfizer
Terminated
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Ischemic Stroke
NCT01208233
All Genders
18+
Years
Multiple Sites
Acute Ischemic Stroke
NCT00827190
All Genders

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now